ConvaTec Group Plc (CNVVF)
USD 2.89
(0.0%)
USD 2.89
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 130.3 Million USD | 107.15% |
| 2022 | 62.9 Million USD | -46.51% |
| 2021 | 117.6 Million USD | 4.53% |
| 2020 | 112.5 Million USD | 1047.96% |
| 2019 | 9.8 Million USD | -95.58% |
| 2018 | 221.6 Million USD | 39.9% |
| 2017 | 158.4 Million USD | 185.29% |
| 2016 | -185.71 Million USD | -106.11% |
| 2015 | -90.1 Million USD | 29.16% |
| 2014 | -127.2 Million USD | -936.84% |
| 2013 | 15.2 Million USD | 109.44% |
| 2012 | -161.1 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 39.3 Million USD | 0.0% |
| 2024 Q1 | 39.3 Million USD | -48.15% |
| 2023 Q4 | 75.79 Million USD | 103.19% |
| 2023 FY | 130.3 Million USD | 107.15% |
| 2023 Q1 | 27.85 Million USD | 85.22% |
| 2023 Q2 | 57.33 Million USD | 105.86% |
| 2023 Q3 | 37.3 Million USD | -34.94% |
| 2022 FY | 62.9 Million USD | -46.51% |
| 2022 Q4 | 15.03 Million USD | 105.98% |
| 2022 Q3 | 7.3 Million USD | -83.9% |
| 2022 Q2 | 45.35 Million USD | 87.79% |
| 2022 Q1 | 24.15 Million USD | -23.45% |
| 2021 Q2 | 85.34 Million USD | 98.95% |
| 2021 FY | 117.6 Million USD | 4.53% |
| 2021 Q1 | 42.9 Million USD | -23.26% |
| 2021 Q3 | 15.9 Million USD | -81.37% |
| 2021 Q4 | 31.54 Million USD | 98.41% |
| 2020 FY | 112.5 Million USD | 1047.96% |
| 2020 Q2 | 57.98 Million USD | 96.24% |
| 2020 Q3 | 26.7 Million USD | -53.96% |
| 2020 Q4 | 55.9 Million USD | 109.37% |
| 2020 Q1 | 29.55 Million USD | 180.92% |
| 2019 Q1 | 22.25 Million USD | -61.97% |
| 2019 FY | 9.8 Million USD | -95.58% |
| 2019 Q4 | -36.51 Million USD | -110.48% |
| 2019 Q3 | -17.35 Million USD | -139.63% |
| 2019 Q2 | 43.77 Million USD | 96.76% |
| 2018 Q2 | 52.3 Million USD | 0.0% |
| 2018 Q1 | 52.3 Million USD | -22.06% |
| 2018 FY | 221.6 Million USD | 39.9% |
| 2018 Q4 | 58.5 Million USD | 0.0% |
| 2018 Q3 | 58.5 Million USD | 11.85% |
| 2017 Q3 | 67.09 Million USD | 454.55% |
| 2017 Q2 | 12.1 Million USD | 0.0% |
| 2017 Q1 | 12.1 Million USD | 118.6% |
| 2017 Q4 | 67.09 Million USD | 0.0% |
| 2017 FY | 158.4 Million USD | 185.29% |
| 2016 Q3 | -65.05 Million USD | -100.77% |
| 2016 Q1 | -40.3 Million USD | -144.09% |
| 2016 Q4 | -65.05 Million USD | 0.0% |
| 2016 Q2 | -32.4 Million USD | 19.6% |
| 2016 FY | -185.71 Million USD | -106.11% |
| 2015 FY | -90.1 Million USD | 29.16% |
| 2015 Q4 | 91.4 Million USD | 372.84% |
| 2015 Q3 | -33.5 Million USD | 56.44% |
| 2015 Q2 | -76.9 Million USD | -3.36% |
| 2015 Q1 | -74.4 Million USD | 46.82% |
| 2014 Q1 | -70.6 Million USD | -9.29% |
| 2014 FY | -127.2 Million USD | -936.84% |
| 2014 Q2 | -52.6 Million USD | 25.5% |
| 2014 Q4 | -139.9 Million USD | -497.86% |
| 2014 Q3 | -23.4 Million USD | 55.51% |
| 2013 Q3 | -24.6 Million USD | 32.79% |
| 2013 Q2 | -36.6 Million USD | 23.59% |
| 2013 FY | 15.2 Million USD | 109.44% |
| 2013 Q4 | -64.59 Million USD | -162.6% |
| 2013 Q1 | -47.9 Million USD | -413.07% |
| 2012 Q4 | 15.3 Million USD | 130.24% |
| 2012 Q3 | -50.6 Million USD | 0.0% |
| 2012 FY | -161.1 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 14157.718% |
| Ansell Limited | 76.5 Million USD | -70.327% |
| Ansell Limited | 76.5 Million USD | -70.327% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -436.651% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 8092.673% |
| Psykey, Inc. | -1.32 Million USD | 9941.754% |
| ConvaTec Group Plc | 130.3 Million USD | 0.0% |
| Encision Inc. | -691.78 Thousand USD | 18935.386% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 91982.858% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 55696.802% |
| Innovative MedTech Inc. | -7.93 Million USD | 1741.286% |
| LifePoint, Inc. | -15.23 Million USD | 955.459% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 2013.082% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 27589.451% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 47577.464% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 28486.068% |
| SmileDirectClub, Inc. | -86.4 Million USD | 250.803% |
| Sector 10, Inc. | 7036.00 USD | -1851804.491% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 93.491% |
| SheerVision, Inc. | -71.37 Thousand USD | 182654.36% |
| United Health Products, Inc. | -2.62 Million USD | 5067.089% |
| Vasamed, Inc. | -4.88 Million USD | 2765.629% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 5555.382% |
| Yubo International Biotech Limited | -1.2 Million USD | 10915.387% |